Crossmark

Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentan

Crossref DOI link: https://doi.org/10.1186/s13063-019-3252-4

Published Online: 2019-03-14

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hostenbach, Stéphanie https://orcid.org/0000-0001-7387-9018
Pauwels, Ayla

Michiels, Veronique

Raeymaekers, Hubert

Van Binst, Anne-Marie

Van Merhaeghen-Wieleman, Annick

Van Schuerbeek, Peter

De Keyser, Jacques

D’Haeseleer, Miguel
Funding

Funding for this research was provided by:

Fondation Charcot
License Information

Text and Data Mining valid from 2019-03-14
More Information

Article History

Received: 16 February 2018

Accepted: 25 February 2019

First Online: 14 March 2019

Ethics approval and consent to participate

: This trial will be conducted in accordance with Good Clinical Practice Guidelines and has been approved by the FAGG and by the Local Ethics Committee of the UZ Brussel (EudraCT 2017–001253-13). Informed consent of all patients will be obtained before the enrolment in the study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.